五皮饮加味联合腹水回输治疗肝硬化难治性腹水的临床观察  

Wupi Decoction combined with ascites reinfusion in the treatment of refractory ascites

作　　者：程红杰[1] 

机构地区：[1]北京市房山区中医医院消化内科,北京102400

出　　处：《中国中西医结合消化杂志》2013年第3期140-142,共3页Chinese Journal of Integrated Traditional and Western Medicine on Digestion

摘　　要：[目的]探讨五皮饮加味联合腹水超滤浓缩回输治疗肝硬化难治性腹水的疗效及安全性。[方法]选择肝硬化难治性腹水住院患者86例,随机分成2组,各43例,治疗组采用五皮饮加味联合腹水回输疗法,对照组采用单纯腹水回输疗法,腹水回输每2周1次,每次3 000～5 000ml,疗程均为2个月,治疗后观察患者体重、腹围、尿量、血浆白蛋白、肝功能、腹水等变化。[结果]2组患者症状均明显好转,其中治疗组总有效率达81.39%,对照组为48.84%,2组比较差异有统计学意义(P<0.05);治疗组患者肝功能、白蛋白、腹围、体重均明显改善,与对照组比较差异有统计学意义(P<0.05)。[结论]五皮饮加味联合腹水回输治疗肝硬化难治性腹水是安全、有效的方法,具有较好的疗效。[Objective]To explore the efficacy and safety of Wupi Decoction combining ascites reinfusion in the treatment of refractory ascites. [Methods]Cases of hospitalized patients with refractory aseites were randomly divided into treatment group and control group. 43 cases in the treatment group were treated with Wupi Decoction combined with ascites reinfusion therapy, while another 43 cases in the control group only received ascites reinfusion therapy. The treatment lasted two months, ascites reinfusion once every two weeks, 3 000-5 000 ml per therapy. At the end of the therapy, the patients＇ weight,abdominal circumfer- ence, urine, plasma albumin, liver function, and ascites change were observed. [Results]The patients＇ symptoms were significantly improved. The total effective rate was 81.39% in the treatment group, and 48. 84% in the control group, indicating significant difference （P〈0.05）. Compared to control group, the liver function, albumin, abdominal circumference, and body weight in treatment group were significantly improved （P〈0.05）. [Conclusion]Wupi Decoction combined with aseites reinfusion in treating refractory ascites is safe and effective.

关 键 词：肝硬化 中药 腹水浓缩回输 难治性腹水 

分 类 号：R575.2[医药卫生—消化系统]